Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20

Authors:

Abstract
V114 (15-valent pneumococcal conjugate vaccine [PCV15]) and a 20-valent PCV (PCV20) are approved for adults (≥18 years) in the United States. We present methodologies to indirectly compare immune r...
Funding Information
  • Merck Sharp & Dohme Corp

This publication has 37 references indexed in Scilit: